NDC 57664-569 - Amlodipine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 57664-569
- Package NDCs from labels
- 57664-569-99, 57664-569-88, 57664-569-13, 57664-569-18
- Manufacturer
- CARACO PHARMACEUTICAL LABORATORIES, LTD.
- Effective date
- 2008-12-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Amlodipine - CARACO PHARMACEUTICAL LABORATORIES, LTD. | CARACO PHARMACEUTICAL LABORATORIES, LTD. | 2008-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57664-569-13 | Amlodipine | 500 in 1 BOTTLE | TABLET | 500 | 1 | |
| 57664-569-18 | Amlodipine | 1000 in 1 BOTTLE | TABLET | 1000 | 1 | |
| 57664-569-88 | Amlodipine | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 57664-569-99 | Amlodipine | 90 in 1 BOTTLE | TABLET | 90 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 57664-569-13 | EA - Each | 57664-569 | 16785f0f-d993-40b4-86a5-5ada750be530 | 1 | 2013-02-13 |
| 57664-569-18 | EA - Each | 57664-569 | 5df3b1d9-e39c-4fb8-af53-d9f8d8a869a4 | 1 | 2013-02-13 |
| 57664-569-99 | EA - Each | 57664-569 | a04536fe-5362-4bc9-b359-6b1d07454578 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Amlodipine besylate | ACTIVE INGREDIENT | 864V2Q084H | AMLODIPINE (AMLODIPINE BESYLATE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.] | 1 | |
| Amlodipine | ACTIVE MOIETY | 1J444QC288 | AMLODIPINE (AMLODIPINE BESYLATE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.] | 1 | |
| butylated hydroxytoluene | INACTIVE INGREDIENT | 1P9D0Z171K | AMLODIPINE (AMLODIPINE BESYLATE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.] | 1 | |
| dibasic calcium phosphate | INACTIVE INGREDIENT | AMLODIPINE (AMLODIPINE BESYLATE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.] | 1 | ||
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | AMLODIPINE (AMLODIPINE BESYLATE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.] | 1 | |
| microcrystalline cellulose | INACTIVE INGREDIENT | OP1R32D61U | AMLODIPINE (AMLODIPINE BESYLATE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.] | 1 | |
| sodium starch glycolate | INACTIVE INGREDIENT | AMLODIPINE (AMLODIPINE BESYLATE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Proficient Rx LP | 410aa0a5-43cf-455c-b51d-7dfbc24eee32 | 2020-02-01 | Warnings, Adverse reactions | 308135 |
| Norvasc | AMLODIPINE BESYLATE | PFIZER LABORATORIES DIV PFIZER INC | abd6a2ca-40c2-485c-bc53-db1c652505ed | 2019-01-15 | Warnings, Adverse reactions | 197361 308136 308135 |
| Amlodipine besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 17e6d552-7528-4597-9498-104cb04f32e7 | 2017-10-25 | Warnings, Adverse reactions | 308135 |
| CB080F88-6B48-7021-8876-4F288E2998FD | b52e2905-f906-4c46-bb24-2c7754c5d75b | 2008-12-15 | Warnings, Adverse reactions | CB080F88-6B48-7021-8876-4F288E2998FD b52e2905-f906-4c46-bb24-2c7754c5d75b |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.